Earlier, experts noted that there are already two effective vaccines against the disease.
The company Moderna, which is known as a manufacturer of an effective vaccine against COVID-19, announced the start of development of a vaccine against monkeypox . The company announced this on its Twitter page.
“As we announced in March 2022 the expansion of the pathogen control program, and because monkeypox is of global importance to health, we are investigating potential vaccines against monkeypox at a preclinical level,” the statement said. p>
Read also: Belgium became the first country in the world to introduce quarantine due to monkeypox
At what stage is the development of this drug, the company has not yet said. But it could be the first targeted monkeypox vaccine.
Subordinating this committee, and as #monkeypox is of Global Public Health importance as identified by the @WHO, there is investigative potential of monkeypox vaccines at the preclinical level. pic.twitter.com/4VfLrxybNn
– Moderna (@moderna_tx) May 23, 2022
Recall, Executive Director of the Coalition for Innovation in Epidemic Preparedness (CEPI) Richard Hatchett said that there are already two effective vaccines against monkeypox. These are vaccines that protect against smallpox. Both pathogens belong to the same group and are quite close.
Symptoms of monkeypox: bumps, fever, muscle aches and headaches. However, such smallpox is less deadly. Read more about the disease in our article.
Important! This publication is based on the latest and current scientific research in the field of medicine and is exclusively general information. Publication cannot be a basis for making any diagnoses. If you get sick or need a diagnosis, see a doctor!
